Leaflet ESCITALOPRAM PHARMASWISS 20mg film-coated tablets


Indicated for: depression

Route of administration: oral

Substance: escitalopram (selective serotonin reuptake inhibitor)

ATC: N06AB10 (Nervous system | Antidepressants | Selective serotonin reuptake inhibitors)

Escitalopram is a medication used to treat major depressive disorder and anxiety disorders, including generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, and social anxiety disorder. It belongs to the class of selective serotonin reuptake inhibitors (SSRIs) and works by increasing serotonin levels in the brain, a neurotransmitter involved in mood regulation.

Escitalopram is taken orally, usually once daily, and therapeutic effects may appear after 1-4 weeks of treatment. It is well-tolerated by most patients but may cause side effects such as nausea, insomnia, drowsiness, dizziness, dry mouth, or decreased libido.

In rare cases, serotonin syndrome, a serious condition caused by excess serotonin, may occur. It is important to use escitalopram as prescribed by a healthcare provider, and discontinuation should be done gradually to avoid withdrawal symptoms such as irritability, dizziness, or sleep disturbances.

General data about ESCITALOPRAM PHARMASWISS 20mg

  • Substance: escitalopram
  • Date of last drug list: 01-07-2013
  • Commercial code: W57282005
  • Concentration: 20mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 20
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for escitalopram

Concentrations available for escitalopram

  • 10mg
  • 15mg
  • 20mg
  • 5mg